Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-111110
Filing Date
2024-10-02
Accepted
2024-10-02 08:15:23
Documents
1
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3712
  Complete submission text file 0000950170-24-111110.txt   5929
Mailing Address AVE NESTLE 55 CH-1800 VEVEY V8
Business Address AVE NESELE 55, CH-1800 VEVEY V8 01141219241111
NESTLE SA (Reporting) CIK: 0000792990 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 241345343
SIC: 2000 Food and Kindred Products
(CF Office: 04 Manufacturing)

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AVENUE NESTLE 55 VEVEY V8 CH-1800
Business Address AVENUE NESTLE 55 VEVEY V8 CH-1800 41-21-924-1111
Societe des Produits Nestle S.A. (Reporting) CIK: 0001803539 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 241345342